FDA Tosses Flu Vaccine Application Back To Moderna With RTF Letter

Agency Cited Phase III Trial Comparator

 
• By Mandy Jackson
  
Moderna's recollection of prior FDA communications refutes CBER director Prasad's RTF letter (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business